Morning Buzz: Aerie Pharmaceuticals (AERI), Acura (ACUR), Great Basin Scientific (GBSN), Coty Inc. (COTY)

Shares of Aerie Pharmaceuticals, Inc. (AERI) are higher by nearly 47% to $19.50 in early trade on Tuesday after the company reported that the FDA has agreed in written and verbal communications that Aerie may change the primary endpoint range of its second Phase 3 registration trial of RhopressaTM, named Rocket 2. “We are extremely […] View the full post at: Morning Buzz: Aerie Pharmaceuticals (AERI), Acura (ACUR), Great Basin Scientific (GBSN), Coty Inc. (COTY) Related posts: Great Basin Bank of Nevada Fails CA: Great Value Play Star Scientific (CIGX) Announces Collaboration with Roskamp Institute on Alzheimer’s Disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.